% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Richter:906021,
author = {Richter, Nils and David, Lara-Sophia and Grothe, Michel J.
and Teipel, Stefan and Dietlein, Markus and Tittgemeyer,
Marc and Neumaier, Bernd and Fink, Gereon R. and Onur,
Oezguer A. and Kukolja, Juraj},
title = {{A}ge and {A}nterior {B}asal {F}orebrain {V}olume {P}redict
the {C}holinergic {D}eficit in {P}atients with {M}ild
{C}ognitive {I}mpairment due to {A}lzheimer’s {D}isease},
journal = {Journal of Alzheimer's disease},
volume = {86},
number = {1},
issn = {1387-2877},
address = {Amsterdam},
publisher = {IOS Press},
reportid = {FZJ-2022-01186},
pages = {425-440},
year = {2022},
abstract = {Abstract.Background: Early and severe neuronal loss in the
cholinergic basal forebrain is observed in Alzheimer’s
disease (AD). Todate, cholinomimetics play a central role in
the symptomatic treatment of AD dementia. Although basic
research indicatesthat a cholinergic deficit is present in
AD before dementia, the efficacy of cholinomimetics in mild
cognitive impairment(MCI) remains controversial. Predictors
of cholinergic impairment could guide individualized
therapy.Objective: To investigate if the extent of the
cholinergic deficit, measured using positron emission
tomography (PET) and thetracer 11C-N-methyl-4-piperidyl
acetate (MP4A), could be predicted from the volume of
cholinergic basal forebrain nucleiin non-demented AD
patients.Methods: Seventeen patients with a high likelihood
of MCI due to AD and 18 age-matched cognitively healthy
adultsunderwent MRI-scanning. Basal forebrain volume was
assessed using voxel-based morphometry and a
cytoarchitectonicatlas of cholinergic nuclei. Cortical
acetylcholinesterase (AChE) activity was measured using
MP4A-PET.Results: Cortical AChE activity and nucleus basalis
of Meynert (Ch4 area) volume were significantly decreased in
MCI.The extent of the cholinergic deficit varied
considerably across patients. Greater volumes of anterior
basal forebrain nuclei(Ch1/2 area) and younger age
(Spearman’s rho(17) = –0.596, $95\%-CI$ [–0.905,
–0.119] and 0.593, $95\%-CI$ [0.092, 0.863]))were
associated with a greater cholinergic deficit.Conclusion:
Data suggest that less atrophy of the Ch1/2 area and younger
age are associated with a more significant
cholinergicdeficit in MCI due to AD. Further investigations
are warranted to determine if the individual response to
cholinomimeticscan be inferred from these measures.Keywords:
Acetylcholinesterase, aging, MP4A, nucleus basalis of
Meynert, positron emission tomography},
cin = {INM-3},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406},
pnm = {5251 - Multilevel Brain Organization and Variability
(POF4-525)},
pid = {G:(DE-HGF)POF4-5251},
typ = {PUB:(DE-HGF)16},
pubmed = {35068451},
UT = {WOS:000768536700025},
doi = {10.3233/JAD-210261},
url = {https://juser.fz-juelich.de/record/906021},
}